FDA approves Pfizer maternal RSV vaccine for infants
August 21, 2023 at 17:43 PM EDT
Pfizer hopes that its respiratory syncytial virus vaccine will be available to the public by the end of October or the beginning of November.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|